Novavax Exec Says Covid Vaccine Pricing In Line With What Other Vaccine Makers Have Suggested, Around $130 Per Dose
Portfolio Pulse from Benzinga Newsdesk
Novavax executive has stated that the pricing for their Covid vaccine is in line with what other vaccine makers have suggested, around $130 per dose.
August 08, 2023 | 1:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novavax's Covid vaccine pricing is consistent with other vaccine makers, which could potentially increase its market competitiveness.
The pricing of Novavax's Covid vaccine is in line with other vaccine makers, which could make it a competitive choice for consumers and governments. This could potentially lead to increased sales and revenue for the company, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100